Global Hemoglobin A1C Analyzer Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Hemoglobin is a protein found in the red blood cells. Its job is to carry oxygen from the lungs to all other parts of the body. Hemoglobin also has the ability to bind with glucose in the bloodstream; this type of bonding is called glycation.
The glycation process is irreversible so glycated hemoglobin (HbA1c) remains in its evolved state for the lifespan of the red blood cell - approximately 8-12 weeks. By measuring the amount of HbA1c in the blood it is possible to determine average blood glucose control over an 8-12 week period. The more HbA1c in your blood, the less controlled a patient’s diabetes is and the more susceptible they are to developing long-term health complications.
HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes.
The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels.
According to our (Global Info Research) latest study, the global Hemoglobin A1C Analyzer market size was valued at US$ 1813 million in 2023 and is forecast to a readjusted size of USD 3289 million by 2030 with a CAGR of 9.0% during review period.
The industry"s leading producers are Abbott Laboratories, Roche and Siemens, with revenues of 19.20%, 13.11% and 7.95% respectively in 2019.
This report is a detailed and comprehensive analysis for global Hemoglobin A1C Analyzer market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Hemoglobin A1C Analyzer market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Hemoglobin A1C Analyzer market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Hemoglobin A1C Analyzer market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Hemoglobin A1C Analyzer market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hemoglobin A1C Analyzer
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hemoglobin A1C Analyzer market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Roche, Siemens, Bio-Rad Laboratories, Tosoh, Danaher Corporation, Trinity Biotech, HUMAN Diagnostics, Arkray, OSANG Healthcare, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Hemoglobin A1C Analyzer market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Bench-top
Compact
Portable
Market segment by Application
Hospital
Homecare
Others
Major players covered
Abbott Laboratories
Roche
Siemens
Bio-Rad Laboratories
Tosoh
Danaher Corporation
Trinity Biotech
HUMAN Diagnostics
Arkray
OSANG Healthcare
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hemoglobin A1C Analyzer product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hemoglobin A1C Analyzer, with price, sales quantity, revenue, and global market share of Hemoglobin A1C Analyzer from 2019 to 2024.
Chapter 3, the Hemoglobin A1C Analyzer competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hemoglobin A1C Analyzer breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Hemoglobin A1C Analyzer market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hemoglobin A1C Analyzer.
Chapter 14 and 15, to describe Hemoglobin A1C Analyzer sales channel, distributors, customers, research findings and conclusion.